Navigation Links
Gel assists head and neck cancer

According to researchers from Northwestern Medical School, an injectable gel may be useful in treating cancers of the head and neck. Head and neck squamous cell carcinoma affects about 20,000 Americans each year.// Given intravenously, the drug cisplatin has been shown to be an effective therapy for head and neck cancers, but because it affects the entire body when given through an IV, it can lead to serious side effects. Researchers studied 120 patients who were previously treated for their cancer.

Nearly 80 percent of the patients had been treated with more than one therapy including surgery, chemotherapy and radiotherapy. Some patients received a new treatment that combines cisplatin and epinephrine in a gel, which is injected directly into the tumor. Other patients received injections of a placebo gel. Tumors were injected up to six times per week over eight weeks.

Tumors responded in nearly 35 percent of the patients who received the cisplatin/epinephrine gel while 20 percent had complete responses. There was only a 5 percent response for those who received the placebo gel. Treatment goals for patients included pain control, wound care, symptom relief and better physical appearance. Patients who received the cisplatin/epinephrine gel met more of their treatment goals than the control group.

Authors of the study write, "Cisplatin/epinephrine injectable gel reduces tumor burden, ameliorates tumor symptoms, and provides a new therapeutic option for treating patients with squamous cell carcinoma of the head and neck."


'"/>




Page: 1

Related medicine news :

1. Arginine food bar assists people with angina
2. Laser technique assists beard problem
3. New drug assists patients suffering premature ejaculation
4. Vitamin B12 can help in detecting cancers
5. Want skin cancer? Please have a cigarette
6. New hope for cancer victims – will vaccine cure the deadly bug
7. Clintons new problem - Is the outgoing American president suffering from skin cancer?
8. Are cancer patients being taken for a ride?
9. Breast cancer treatment to be determined by gene test
10. Ductal lavage may detect early breast cancer
11. Beware of the oral patch! It could be cancer!!!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: